Evidence for the Role of Peroxisome Proliferator-Activated Receptor-β/δ in the Development of Spinal Cord Injury

被引:42
|
作者
Paterniti, Irene [1 ]
Esposito, Emanuela [1 ,3 ]
Mazzon, Emanuela [1 ]
Galuppo, Maria [1 ]
Di Paola, Rosanna [3 ]
Bramanti, Placido [3 ]
Kapoor, Amar [2 ]
Thiemermann, Christoph [2 ]
Cuzzocrea, Salvatore [3 ]
机构
[1] Univ Messina, Sch Med, Dept Clin & Expt Med & Pharmacol, Torre Biol Policlin Univ, I-98100 Messina, Italy
[2] St Bartholomews & Royal London Sch Med & Dent, Ctr Expt Med Nephrol & Crit Care, William Harvey Res Inst, London, England
[3] Ctr Neurolesi Bonino Pulejo, Inst Ricovero & Cura Carattere Sci, Messina, Italy
关键词
CYTOKINE PRODUCTION; IN-VIVO; MECHANISMS; APOPTOSIS; LIPOPOLYSACCHARIDE; DIFFERENTIATION; INFLAMMATION; EXPRESSION; LIGANDS; ATHEROSCLEROSIS;
D O I
10.1124/jpet.110.165605
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Several lines of evidence suggest a biological role for peroxisome proliferator-activated receptor (PPAR)-beta/delta in the pathogenesis many diseases. The aim of the present study was to evaluate the contribution of PPAR-beta/delta in the secondary damage in experimental spinal cord injury (SCI) in mice. To this purpose, we used 4-[[[2-[3-fluoro-4-(trifluoromethyl)phenyl]-4-methyl-5-thiazolyl]methyl]thio]-2-methylphenoxy]acetic acid (GW0742), a high-affinity PPAR-beta/delta agonist. Spinal cord trauma was induced by the application of vascular clips (force of 24 g) to the dura via a four-level T-5 to T-8 laminectomy. SCI in mice resulted in severe trauma characterized by edema, neutrophil infiltration, production of inflammatory mediators, tissue damage, and apoptosis. GW0742 treatment (0.3 mg kg(-1) i.p.) 1 and 6 h after the SCI significantly reduced 1) the degree of spinal cord inflammation and tissue injury (histological score), 2) neutrophil infiltration (myeloperoxidase activity), 3) nitrotyrosine formation, 4) proinflammatory cytokines expression, 5) nuclear factor-kappa B activation, 6) inducible nitric-oxide synthase expression, and 6) apoptosis (terminal deoxynucleotidyl transferase dUTP nick-end labeling staining, FasL, Bax, and Bcl-2 expression). Moreover, GW0742 significantly ameliorated the recovery of limb function (evaluated by motor recovery score). To elucidate whether the protective effects of GW0742 are related to activation of the PPAR-beta/delta receptor, we also investigated the effect of PPAR-beta/delta antagonist methyl-3-({[2-(methoxy)-4-phenyl]amino}sulfonyl)-2-thiophenecarboxylate (GSK0660) on the protective effects of GW0742. GSK0660 (1 mg/kg i.p. 30 min before treatment with GW0742) significantly blocked the effect of the PPAR-beta/delta agonist and thus abolished the protective effect. Our results clearly demonstrate that GW0742 treatment reduces the development of inflammation and tissue injury associated with spinal cord trauma.
引用
收藏
页码:465 / 477
页数:13
相关论文
共 50 条
  • [1] Inflammation in diabetes mellitus:: Role of peroxisome proliferator-activated receptor-α and peroxisome proliferator-activated receptor-γ agonists
    Libby, Peter
    Plutzky, Jorge
    AMERICAN JOURNAL OF CARDIOLOGY, 2007, 99 (4A): : 27B - 40B
  • [2] Comparative neuroprotective effects of methylprednisolone and rosiglitazone, a peroxisome proliferator-activated receptor-γ following spinal cord injury
    Zhang, Qin
    Huang, Chen
    Tang, Tiansi
    Shi, Qin
    Yang, Huilin
    NEUROSCIENCES, 2011, 16 (01) : 46 - 52
  • [3] Spinal cord injury causes bone loss through peroxisome proliferator-activated receptor-γ and Wnt signalling
    Yan, Jun
    Li, Bo
    Chen, Jiang-Wei
    Jiang, Sheng-Dan
    Jiang, Lei-Sheng
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2012, 16 (12) : 2968 - 2977
  • [4] Peroxisome proliferator-activated receptor-γ agonist rosiglitazone reduces secondary damage in experimental spinal cord injury
    Li, Xigong
    Du, Junhua
    Xu, Sanzhong
    Lin, Xiangjin
    Ling, Zhiheng
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2013, 41 (01) : 153 - 161
  • [5] Role of Peroxisome Proliferator-Activated Receptor-γ in Atherosclerosis - An Update
    Wang, Nanping
    Yin, Ruiying
    Liu, Yan
    Mao, Guangmei
    Xi, Fang
    CIRCULATION JOURNAL, 2011, 75 (03) : 528 - 535
  • [6] Role of peroxisome proliferator-activated receptor-γ in hematologic malignancies
    Konopleva, M
    Andreeff, M
    CURRENT OPINION IN HEMATOLOGY, 2002, 9 (04) : 294 - 302
  • [7] The Role of Peroxisome Proliferator-Activated Receptor-γ in Breast Cancer
    Kotta-Loizou, Ioly
    Giaginis, Constantinos
    Theocharis, Stamatios
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2012, 12 (09) : 1025 - 1044
  • [8] Peroxisome proliferator-activated receptor-γ and lipodystrophy
    Tantsma, Jouke T.
    Rabelink, Ton J.
    FUTURE LIPIDOLOGY, 2006, 1 (04): : 455 - 462
  • [9] Peroxisome proliferator-activated receptor-α regulates postischemic liver injury
    Okaya, T
    Lentsch, AB
    AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2004, 286 (04): : G606 - G612
  • [10] Evidence Implicating Peroxisome Proliferator-Activated Receptor-γ in the Pathogenesis of Preeclampsia
    McCarthy, Fergus P.
    Drewlo, Sascha
    English, Fred A.
    Kingdom, John
    Johns, Edward J.
    Kenny, Louise C.
    Walsh, Sarah K.
    HYPERTENSION, 2011, 58 (05) : 882 - U447